We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Urges Sponsors to Discuss Enrichment Trial Designs Early
FDA Urges Sponsors to Discuss Enrichment Trial Designs Early
January 30, 2013
The FDA is strongly urging drugmakers to discuss enrichment trial designs with the agency early in the design process, due to the complex nature of interpreting the data the studies generate.